Today I have received my first batch of Faster Insulin Aspart (Faster Novolog if you like) from the pharmacist. It’s going to be interesting to see how it compares to good old Novolog, my previous fast acting. It’s first test is a five minute pre-bolus versus a Krispy Kreme donut…
Woo hoo! I talked to my Consultant (Endo) at my last review and he was happy for me to switch as soon as Fisasp was released. I will contact him and ask him to send the letter of recommendation to my GP
I’ll be interested to hear how it goes! It’s been approved here in Canada as well (though I’m not sure it’s on the market quite yet, I heard late spring), and I’ll be getting a prescription from my endocrinologist when I see him in April.
F[quote=“MarieB, post:17, topic:60489”]
Jen I just saw a press release, it’s been approved for Canada—I’ll try to find that for you
Yep, it’s been approved, but I’ve heard it won’t be on the market until late spring (but it sounds like it might be available now?). I’m going to get a prescription for it when I see my endocrinologist in April.
I feel the opposite - but I suppose that’s why there are different options. I like the shorter Apidra tail because it allows me to be more aggressive with dosing, and especially corrections, with less fear of unexpected lows hours later. This is especially helpful on days when I have somewhat less control over meal times, such as holidays or weddings.
Knowing that, also helps me schedule corrections (or extended boluses) for those higher-protein or high fat meals. Having a shorter tail makes that a lot simpler for me.